ENO1 and pancreatic adenocarcinoma: The α-Enolase (ENO1) specific Th17 cells have specific anticancer effects in PAAD patients, and compared with healthy mucosa, the abundance of Th17 in peripheral blood of tumor patients is low, while the proportion of FOXP3+Tregs is high.